Runx regulation of sphingolipid metabolism and survival signaling

Anna Kilbey1, Anne Terry, Alma Jenkins

  • 1Molecular Oncology Laboratory, Faculty of Veterinary Medicine, Institute of Comparative Medicine, University of Glasgow, Glasgow, United Kingdom. A.Kilbey@vet.gla.ac.uk

Cancer Research
|July 1, 2010
PubMed

Insights

Runx genes regulate cell fate and cancer. Ectopic Runx expression promotes cancer cell survival by altering sphingolipid metabolism and resisting apoptosis, revealing a link between transcription factors and lipid signaling in cancer.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Runx genes (Runx1, 2, and 3) are critical for cell fate during development.
  • In cancer, Runx genes can function as oncogenes or tumor suppressors.
  • Ectopic Runx expression is linked to oncogenic functions, including resistance to apoptosis.

Purpose of the Study:

  • To identify gene targets responsible for the apoptosis-resistant phenotype associated with ectopic Runx expression.
  • To investigate the role of sphingolipid metabolism in Runx-mediated cancer cell survival.

Main Methods:

  • Identified direct transcriptional targets of Runx in sphingolipid metabolism (Sgpp1, Ugcg, St3gal5/Siat9).
  • Utilized mass spectrometry to analyze changes in ceramide and sphingosine 1 phosphate levels.
  • Assessed the impact of Runx expression on apoptosis signaling pathways (c-Jun-NH(2)-kinase and p38(MAPK)).

Main Results:

  • Ectopic Runx directly targets key sphingolipid metabolism enzymes, altering lipid profiles.
  • Runx expression reduced intracellular long-chain ceramides and increased extracellular sphingosine 1 phosphate.
  • Runx opposed c-Jun-NH(2)-kinase and p38(MAPK) activation, suppressing apoptosis induced by TNF-alpha.

Conclusions:

  • Runx transcription factors directly regulate sphingolipid metabolism enzymes.
  • This regulation contributes to cancer cell survival and chemoresistance by modulating lipid signaling.
  • Reveals a novel connection between oncogenic transcription factors and lipid pathways in cancer.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...